Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387733 (US10294214, Example 33) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 2.51E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387735 (US10294214, Example 35) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.59E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387743 (US10294214, Example 43) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 398 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387747 (US10294214, Example 47) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 631 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387756 (US10294214, Example 56) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.26E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387768 (US10294214, Example 68) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 398 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387769 (US10294214, Example 69) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 501 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387772 (US10294214, Example 72) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 501 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387780 (US10294214, Example 80) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387702 (Synthesis of N-(2-(cyclopropanecarbonyl)-1H-indol-...) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 501 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387707 (US10294214, Example 7) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 398 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387711 (US10294214, Example 11) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 316 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387714 (US10294214, Example 14) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 631 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387721 (US10294214, Example 21) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 631 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387737 (US10294214, Example 37) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 251 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387738 (US10294214, Example 38) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 251 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387750 (US10294214, Example 50) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 794 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387751 (US10294214, Example 51) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387752 (US10294214, Example 52) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.26E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387753 (US10294214, Example 53) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387759 (US10294214, Example 59) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387760 (US10294214, Example 60) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387762 (US10294214, Example 62) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 251 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387773 (US10294214, Example 73) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 631 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387703 (Synthesis of methyl 3-(2-(4-cyclohexylpiperidin-1-...) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387704 (US10294214, Example 4) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 316 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387717 (US10294214, Example 17) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 631 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387725 (US10294214, Example 25) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387758 (US10294214, Example 58) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 79.4 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387706 (US10294214, Example 6) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 398 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387713 (US10294214, Example 13) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 501 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387716 (US10294214, Example 16) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 631 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387720 (US10294214, Example 20) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 631 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387727 (US10294214, Example 27) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.26E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387741 (US10294214, Example 41) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 398 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387754 (US10294214, Example 54) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387755 (US10294214, Example 55) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.59E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387763 (US10294214, Example 63) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387775 (US10294214, Example 75) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.26E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387705 (US10294214, Example 5) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 316 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387723 (US10294214, Example 23) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 794 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387730 (US10294214, Example 30) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.26E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387734 (US10294214, Example 34) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387742 (US10294214, Example 42) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 316 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387745 (US10294214, Example 45) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 501 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387757 (US10294214, Example 57) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 2.51E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387761 (US10294214, Example 61) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 251 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387770 (US10294214, Example 70) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 398 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387774 (US10294214, Example 74) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 631 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387708 (US10294214, Example 8) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 316 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387710 (US10294214, Example 10) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 316 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387715 (US10294214, Example 15) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 631 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387718 (US10294214, Example 18) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 794 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387726 (US10294214, Example 26) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387744 (US10294214, Example 44) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 398 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387748 (US10294214, Example 48) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 501 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387767 (US10294214, Example 67) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 316 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387778 (US10294214, Example 78) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387709 (US10294214, Example 9) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 398 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387719 (US10294214, Example 19) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 631 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387729 (US10294214, Example 29) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.26E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387731 (US10294214, Example 31) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.59E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387740 (US10294214, Example 40) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 316 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387764 (US10294214, Example 64) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 251 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387765 (US10294214, Example 65) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 316 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387766 (US10294214, Example 66) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 251 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387776 (US10294214, Example 76) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387777 (US10294214, Example 77) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.59E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387701 (Synthesis of 2-(4-(tert-butyl)piperidin-1-yl)-N-(2...) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 631 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387712 (US10294214, Example 12) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 501 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387722 (US10294214, Example 22) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 631 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387724 (US10294214, Example 24) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387728 (US10294214, Example 28) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.59E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387732 (US10294214, Example 32) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.59E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387736 (US10294214, Example 36) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 1.59E+3 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387739 (US10294214, Example 39) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 251 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387746 (US10294214, Example 46) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 501 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387749 (US10294214, Example 49) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 631 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387771 (US10294214, Example 71) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 398 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Melanocortin receptor 4 (Homo sapiens (Human)) | BDBM387779 (US10294214, Example 79) | KEGG UniProtKB/SwissProt GoogleScholar | UniChem | US Patent | n/a | n/a | n/a | n/a | 794 | n/a | n/a | n/a | n/a |
Vanderbilt University; King''s College London; Glaxo Group Limited US Patent | Assay Description Analysis of pharmacological properties of compounds was performed using the LANCE cAMP kit (Perkin Elmer). HEK293 cells stably expressing the hMC4R w... | US Patent US10294214 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
